Literature DB >> 1849016

A new fluorescence method to detect singlet oxygen inside phospholipid model membranes.

M Wozniak1, F Tanfani, E Bertoli, G Zolese, J Antosiewicz.   

Abstract

A fluorescence method for detecting singlet oxygen (1O2) in model membranes is proposed. 1O2 was generated by hydrogen peroxide/sodium hypochlorite system. 1,3-Diphenylisobenzofuran (DPBF), a specific 1O2 trap, dissolved in organic solvents gives a strong fluorescence spectrum when excited at 410 nm. A similar spectrum, with a maximum at 455 nm, is obtained when DPBF is incorporated in unilamellar dipalmitoylphosphatidylcholine liposomes. The intensity of fluorescence spectrum decreases when DPBF-labeled liposomes are exposed to singlet oxygen. This decrease is sensitive to 1O2 traps and quenchers like tryptophan and sodium azide, to lipid membrane fluidity and to the concentration of sodium hypochlorite and hydrogen peroxide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849016     DOI: 10.1016/0005-2760(91)90304-z

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  A fluorescent nanoprobe for real-time monitoring of intracellular singlet oxygen during photodynamic therapy.

Authors:  Jian-Tao Ping; Hong-Shang Peng; Jinglei Qin; Fang-Tian You; Yi-Quan Wang; Gen-Xiang Chen; Min Song
Journal:  Mikrochim Acta       Date:  2018-04-26       Impact factor: 5.833

2.  Study on Liposomal Encapsulation of New Bodipy Sensitizers for Photodynamic Therapy.

Authors:  Thumuganti Gayathri; A Vijayalakshmi; Sreejith Mangalath; Joshy Joseph; N Madhusudhana Rao; Surya Prakash Singh
Journal:  ACS Med Chem Lett       Date:  2018-02-04       Impact factor: 4.345

3.  Clean Photothermal Heating and Controlled Release from Near-Infrared Dye Doped Nanoparticles without Oxygen Photosensitization.

Authors:  Samit Guha; Scott K Shaw; Graeme T Spence; Felicia M Roland; Bradley D Smith
Journal:  Langmuir       Date:  2015-07-07       Impact factor: 3.882

Review 4.  Use of fluorescent probes for ROS to tease apart Type I and Type II photochemical pathways in photodynamic therapy.

Authors:  Maria Garcia-Diaz; Ying-Ying Huang; Michael R Hamblin
Journal:  Methods       Date:  2016-07-01       Impact factor: 3.608

5.  Bioorthogonal Turn-On BODIPY-Peptide Photosensitizers for Tailored Photodynamic Therapy.

Authors:  Greta Linden; Olalla Vázquez
Journal:  Chemistry       Date:  2020-07-23       Impact factor: 5.236

6.  Highly-controllable drug release from core cross-linked singlet oxygen-responsive nanoparticles for cancer therapy.

Authors:  Jiayan Zhou; Chunyang Sun; Chunshui Yu
Journal:  RSC Adv       Date:  2020-05-27       Impact factor: 4.036

7.  Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy.

Authors:  Amreddy Narsireddy; Kurra Vijayashree; Mahesh G Adimoolam; Sunkara V Manorama; Nalam M Rao
Journal:  Int J Nanomedicine       Date:  2015-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.